• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

February 10, 2012: Cellular, Tissue and Gene Therapies Meeting: Agenda

Meeting, #55, Teleconference
National Institutes of Health, Building 29B, Conference Room A-B
Bethesda, Maryland
February 10, 2012

Open Session    
2:00 p.m. (EST) Call to Order and Opening Remarks
Roll Call
Conflict of Interest Statement
Steven Dubinett, M.D., Chair
Gail Dapolito
Designated Federal Officer
2:10 Overview - Research Program
Center for Biologics Evaluation
and Research (CBER), FDA
Carolyn Wilson, Ph.D.
Associate Director for Research, CBER
2:30 Q&A  
2:35 Overview – Research Programs
Office of Cellular, Tissue and
Gene Therapies, Division of Cellular
and Gene Therapies, CBER, FDA
Raj Puri, M.D., Ph.D.
Director, Division of Cellular and Gene
Therapies, FDA
2:45 Q&A  
2:50 Research Highlights – Gene and
Tissue Therapy Branch, Division of
Cellular, Tissue and Gene Therapies

Steven Bauer, Ph.D.
Chief, Cellular and Tissue Therapy Branch, FDA

3:10 Q&A  
3:20 Open Public Hearing  
4:20 Closed Session  
5:00 p.m. Adjourn